Showing results (31-40 of 108) with videos related to

Sort By:
Pageof 11
Inflammation and Regeneration|June 12, 2019
The role of interleukin-1 in general pathologyNaoe Kaneko, Mie Kurata, Toshihiro Yamamoto, et al.
International Journal of Immunopathology and Pharmacology|August 16, 2021
Insulin amyloid fibrils interact directly with the NLRP3, resulting in inflammasome activation and pyroptotic cell deathWakako Mori, Naoe Kaneko, Ayaka Nakanishi, et al.
Nihon Rinsho. Japanese Journal of Clinical Medicine|August 24, 2013
[The inflammasome]Chikara Okumura, Kaho Haraikawa, Satomi Suehiro, et al.
Cell Death and Differentiation|May 16, 2021
A comprehensive interaction study provides a potential domain interaction network of human death domain superfamily proteinsWei Zhou, Naoe Kaneko, Tomoya Nakagita, et al.
The Journal of Biological Chemistry|March 17, 2004
Cryopyrin-induced interleukin 1beta secretion in monocytic cells: enhanced activity of disease-associated mutants and requirement for ASCTheresa A Dowds, Junya Masumoto, Li Zhu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 4, 2007
Prognostic significance of the immunohistochemical staining of cleaved caspase-3, an activated form of caspase-3, in gliomasTatsuya Kobayashi, Junya Masumoto, Tsuyoshi Tada, et al.
Clinical Journal of Gastroenterology|February 8, 2026
An autopsy case of multiple liver metastases from minute pancreatic acinar cell carcinoma clinically diagnosed as primary hepatic acinar cell carcinomaYusuke Okujima, Fujimasa Tada, Hidehiro Murakami, et al.
Clinical and Experimental Nephrology|January 9, 2010
Granulomatous transformation of capillary lesions in pulmonary-renal syndrome autologously induced anti-glomerular basement membrane disease in Wistar-Kyoto ratsDaiju Aoyagi, Koh Nakazawa, Tomoki Kaneyama, et al.
SAGE Open Medical Case Reports|August 5, 2016
Tocilizumab improved clinical symptoms of a patient with systemic tophaceous gout who had symmetric polyarthritis and fever: An alternative treatment by blockade of interleukin-6 signalingSho Mokuda, Masamoto Kanno, Kiyoshi Takasugi, et al.
Endocrine, Metabolic & Immune Disorders Drug Targets|September 4, 2015
IL-1 as a target in inflammationYuki Ito, Naoe Kaneko, Tomoyuki Iwasaki, et al.
Pageof 11